Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Axon Patch-Clamp | Molecular DevicesAxon Patch-Clamp | Molecular Devices
VS
RocheRoche
Axon Patch-Clamp | Molecular Devices

Axon Patch-Clamp | Molecular Devices

3860 N 1st St, San Jose, 95134, US

Last Update: 17/02/2026

View Profile

We provide comprehensive workflow solutions for patch-clamp electrophysiology that includes amplifiers, digitizer, software, and accessories. The Axon Instruments® portfolio facilitates the entire range of patch-clamp technique experiments from the smallest single-chann...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:None
Subsidiaries:67
12-month incidents
0
Known data breaches
0
Attack type number
0
Roche

Roche

Grenzacherstrasse, Switzerland 🇨🇭 , 4070, CH

Last Update: 17/09/2026

View Profile
Between 800 and 849
http://www.roche.com/
836/1000Good

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to ...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:103,689
Subsidiaries:51
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Axon Patch-Clamp | Molecular Devices

Axon Patch-Clamp | Molecular Devices

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Roche

Roche

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Axon Patch-Clamp | Molecular Devices in 2026.

Incidents

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Roche in 2026.

Incidents

Incident History - Axon Patch-Clamp | Molecular Devices (X = Date, Y = Severity)

Axon Patch-Clamp | Molecular Devices cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Roche (X = Date, Y = Severity)

Roche cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Axon Patch-Clamp | Molecular Devices

Axon Patch-Clamp | Molecular Devices

Incidents
No explicit notable incidents reported.
Roche

Roche

Incidents
No explicit notable incidents reported.

FAQ

Between Axon Patch-Clamp | Molecular Devices company and Roche company, which one has the best AI Cybersecurity Score ?
Between Axon Patch-Clamp | Molecular Devices company and Roche company, which one has experienced more cyber incidents in the past ?
Between Axon Patch-Clamp | Molecular Devices company and Roche company, which one has experienced more cyber incidents this year ?
Between Axon Patch-Clamp | Molecular Devices company and Roche company, which one has experienced at least one ransomware attack ?
Between Axon Patch-Clamp | Molecular Devices company and Roche company, which one has experienced at least one data breach ?
Between Axon Patch-Clamp | Molecular Devices company and Roche company, which one has experienced at least one targeted cyberattack ?
Between Axon Patch-Clamp | Molecular Devices company and Roche company, which one has experienced at least one vulnerability ?
Between Axon Patch-Clamp | Molecular Devices company and Roche company, which one holds the most compliance certifications ?
Between Axon Patch-Clamp | Molecular Devices company and Roche company, which one holds the fewest compliance certifications ?
Between Axon Patch-Clamp | Molecular Devices company and Roche company, which one has the most subsidiaries ?
Between Axon Patch-Clamp | Molecular Devices company and Roche company, which one has the largest number of employees ?
Between Axon Patch-Clamp | Molecular Devices and Roche, which company holds both SOC 2 Type 1 certifications ?
Between Axon Patch-Clamp | Molecular Devices and Roche, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Axon Patch-Clamp | Molecular Devices or Roche ?
Which company is PCI DSS compliant - Axon Patch-Clamp | Molecular Devices or Roche ?
Between Axon Patch-Clamp | Molecular Devices and Roche, which company complies with HIPAA regulations for healthcare data ?
Between Axon Patch-Clamp | Molecular Devices and Roche, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-94057
SUMMARY

Exim before 4.100.1 allows SMTP smuggling in which the received message does not match any sent message, and instead depends on crafted data sent after a rejection during DATA processing.

PUBLISHED
Date2026-09-19
UPDATED
Date2026-09-19
RISK INFORMATION (Score: 4)
CVSS3
Base Score: 4.0
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:L/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
2.2
CVE-2026-94056
SUMMARY

Exim before 4.100.1, when Proxy-Protocol is used with an attacker-controlled proxy, allows attackers to read certain uninitialized data from stack memory.

PUBLISHED
Date2026-09-19
UPDATED
Date2026-09-19
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:H/I:N/A:L
IMPACT SCORE
4.7
EXPLOITABILITY
2.2
CVE-2026-94055
SUMMARY

Exim before 4.100.1, when certain non-default TLS settings are used with GnuTLS, has a use-after-free.

PUBLISHED
Date2026-09-19
UPDATED
Date2026-09-19
RISK INFORMATION (Score: 3.7)
CVSS3
Base Score: 3.7
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:N/A:L
IMPACT SCORE
1.4
EXPLOITABILITY
2.2
CVE-2026-94054
SUMMARY

Exim before 4.100.1, when Proxy-Protocol is used with an attacker-controlled proxy, has an out-of-bounds write.

PUBLISHED
Date2026-09-19
UPDATED
Date2026-09-19
RISK INFORMATION (Score: 7)
CVSS3
Base Score: 7.0
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:L/I:H/A:L
IMPACT SCORE
4.7
EXPLOITABILITY
2.2
CVE-2026-93993
SUMMARY

Mistral Vibe before 2.25.5 contains a remote code execution vulnerability in the worktree creation process that executes git hooks before trust validation. Attackers can supply a repository with a crafted post-checkout hook that executes arbitrary shell commands with the privileges of the user running Vibe.

PUBLISHED
Date2026-09-19
UPDATED
Date2026-09-19
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
CVSS4
Base Score: 8.6
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:A/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
2.8